In conclusion, PCSK9-i therapy significantly ameliorated the lipid profile, inflammatory status and PWV values in a cohort of FH subjects; moreover, ∆ PWV was significantly associated with ∆ LDL-C, ∆ NC and ∆ MHR. This evidence concerns the gene PCSK9 and familial hyperaldosteronism.